PL377492A1 - Atropoizomery pochodnych 3-podstawionego-4-arylochinolin-2-onu - Google Patents

Atropoizomery pochodnych 3-podstawionego-4-arylochinolin-2-onu

Info

Publication number
PL377492A1
PL377492A1 PL377492A PL37749203A PL377492A1 PL 377492 A1 PL377492 A1 PL 377492A1 PL 377492 A PL377492 A PL 377492A PL 37749203 A PL37749203 A PL 37749203A PL 377492 A1 PL377492 A1 PL 377492A1
Authority
PL
Poland
Prior art keywords
sup
atropisomers
arylquinolin
derivatives
substituted
Prior art date
Application number
PL377492A
Other languages
English (en)
Inventor
Vivekananda M. Vrudhula
Valentin Kala Gribkoff
Bireshwar Dasgupta
Christopher G. Boissard
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of PL377492A1 publication Critical patent/PL377492A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PL377492A 2002-12-23 2003-12-18 Atropoizomery pochodnych 3-podstawionego-4-arylochinolin-2-onu PL377492A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43616002P 2002-12-23 2002-12-23

Publications (1)

Publication Number Publication Date
PL377492A1 true PL377492A1 (pl) 2006-02-06

Family

ID=32682352

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377492A PL377492A1 (pl) 2002-12-23 2003-12-18 Atropoizomery pochodnych 3-podstawionego-4-arylochinolin-2-onu

Country Status (19)

Country Link
US (1) US6939968B2 (pl)
EP (1) EP1575589B1 (pl)
JP (1) JP2006512378A (pl)
KR (1) KR20050102081A (pl)
CN (1) CN1750821A (pl)
AT (1) ATE472328T1 (pl)
AU (1) AU2003300425A1 (pl)
BR (1) BR0317679A (pl)
CZ (1) CZ2005407A3 (pl)
DE (1) DE60333226D1 (pl)
IL (1) IL169294A (pl)
MX (1) MXPA05006814A (pl)
NO (1) NO20053078L (pl)
NZ (1) NZ541237A (pl)
PL (1) PL377492A1 (pl)
RU (1) RU2352563C2 (pl)
TR (1) TR200502440T2 (pl)
WO (1) WO2004058260A1 (pl)
ZA (1) ZA200505077B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133330B1 (en) * 2007-04-09 2014-01-01 Daiichi Sankyo Company, Limited Atropisomer of pyrrole derivative
US8680116B2 (en) 2009-07-22 2014-03-25 Merck Sharp & Dohme Corp. Quinolinone PDE2 inhibitors
CN105164105B (zh) 2013-04-10 2018-01-30 第一三共株式会社 吡咯衍生物的结晶及其制备方法
KR20220079878A (ko) * 2019-10-07 2022-06-14 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로비시클릭 화합물
JP7780439B2 (ja) * 2019-10-07 2025-12-04 ディー．イー．ショウ リサーチ，エルエルシー Ｋｖ１．３カリウムシェーカーチャネル遮断薬としてのアリール複素二環式化合物
PY2125608A (es) * 2020-04-01 2021-12-28 Fmc Corp Atropisómeros de derivados de piridazinona como herbicidas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU1774624C (ru) * 1990-11-11 1995-02-09 Украинская фармацевтическая академия Диэтиламиноэтиламида 1-пропил-2-оксо-4-гидроксихинолин-3-карбоновой кислоты гидрохлорид, проявляющий анестезирующую, противоаритмическую, антиоксидантную, антимикробную и фунгицидную активность
TW504504B (en) 1996-11-26 2002-10-01 Bristol Myers Squibb Co 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
SK113299A3 (en) * 1997-02-28 2001-05-10 Pfizer Prod Inc Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
PT1133474E (pt) * 1998-12-04 2007-04-30 Bristol Myers Squibb Co Derivados da 4-arilquinolin-2-ona substituidos em 3 posições utilizados como moduladores do canal de potássio.
TW562799B (en) * 1999-12-01 2003-11-21 Bristol Myers Squibb Co Preparation of 3-substituted-4-arylquinolin-2-one derivatives
JP2004521892A (ja) * 2000-12-20 2004-07-22 メルク　エンド　カムパニー　インコーポレーテッド （ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤

Also Published As

Publication number Publication date
WO2004058260A1 (en) 2004-07-15
EP1575589A4 (en) 2008-05-21
ZA200505077B (en) 2006-09-27
US6939968B2 (en) 2005-09-06
NO20053078L (no) 2005-08-29
JP2006512378A (ja) 2006-04-13
KR20050102081A (ko) 2005-10-25
EP1575589B1 (en) 2010-06-30
US20040147749A1 (en) 2004-07-29
RU2005123046A (ru) 2006-01-20
NZ541237A (en) 2008-09-26
IL169294A (en) 2010-11-30
EP1575589A1 (en) 2005-09-21
ATE472328T1 (de) 2010-07-15
MXPA05006814A (es) 2005-09-08
DE60333226D1 (de) 2010-08-12
TR200502440T2 (tr) 2005-10-21
NO20053078D0 (no) 2005-06-23
AU2003300425A1 (en) 2004-07-22
RU2352563C2 (ru) 2009-04-20
BR0317679A (pt) 2005-11-29
CN1750821A (zh) 2006-03-22
CZ2005407A3 (cs) 2005-10-12

Similar Documents

Publication Publication Date Title
NZ510987A (en) 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
MY135841A (en) Novel benzodioxoles
BG106013A (en) New compounds and compositions as protease inhibitors
JO2282B1 (en) Oxazole derivatives
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
GB0114286D0 (en) Nucleoside Derivatives
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
AU2004263179A8 (en) Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
IL164511A0 (en) Heterocyclic compounds
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
PL361355A1 (pl) Pochodne fenyloglicyny
IL164509A0 (en) Furyl compounds
DE602004011394D1 (en) Thiazolderivate
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
TW200716628A (en) Novel compounds
BR0211972A (pt) Composição oftálmica
SE0402762D0 (sv) Indazole sulphonamide derivatives
GB0314967D0 (en) Piperazine derivatives
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200616976A (en) Pyrimidine derivatives
MXPA05009282A (es) Derivados de anilina sustituidos.
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)